Back
Neurogene Vs. AIM ImmunoTech Industry Stock Comparison
Sell
9
NGNE
Neurogene
Last Price:
$17.75
Seasonality Move:
-11.99%
Sell
15
AIM
AIM ImmunoTech
Last Price:
$0.14
Seasonality Move:
8.18%
Sell
15
AIM ImmunoTech (AIM)
is a Sell
Is AIM ImmunoTech a Buy, Sell or Hold?
-
The current AIM ImmunoTech [AIM] share price is $0.13. The Score for AIM is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
AIM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
AIM Stock Price Chart
What is AIM ImmunoTech's stock price today?
-
The AIM ImmunoTech share price today is $0.13The current trend is relatively stagnant and AIM is experiencing slight buying pressure.
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 47.3 | Sell |
Chaikin Money Flow: | -66350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.64 - 19.74) | Buy |
Bollinger Bands (100): | (16.56 - 46.82) | Sell |
AIM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 28.34 | Sell |
Chaikin Money Flow: | -234134 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.16 - 0.22) | Sell |
Bollinger Bands (100): | (0.19 - 0.25) | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.72 | Sell |
20-day SMA: | 17.5 | Buy |
50-day SMA: | 20.28 | Sell |
200-day SMA: | 34.25 | Sell |
8-day EMA: | 18.71 | Sell |
20-day EMA: | 18.67 | Sell |
50-day EMA: | 21.89 | Sell |
200-day EMA: | 30.19 | Sell |
AIM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.14 | Sell |
20-day SMA: | 0.18 | Sell |
50-day SMA: | 0.2 | Sell |
200-day SMA: | 0.29 | Sell |
8-day EMA: | 0.15 | Sell |
20-day EMA: | 0.17 | Sell |
50-day EMA: | 0.2 | Sell |
200-day EMA: | 0.28 | Sell |
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.
AIM ImmunoTech Earnings Growth & AIM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.09 per share.
Neurogene Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AIM ImmunoTech Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |